Top compounds associated with response to STRA13


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.03
mRNA Cyclopamine FIMM pan-cancer AAC -0.35 0.03
mRNA erastin CTRPv2 pan-cancer AAC -0.082 0.03
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.3 0.03
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.074 0.03
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.099 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.03
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.076 0.03
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.072 0.03
mRNA rTRAIL GDSC1000 pan-cancer AAC 0.078 0.03
Download CSV